Intercure Ltd. (INCR)
Market Closed
25 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary 
TASE $
1. 55
+0.01
+0.65%
$
85.58M Market Cap
- P/E Ratio
0% Div Yield
29,042 Volume
- Eps
$ 1.54
Previous Close Day Range
1.54 1.57
Year Range
1.17 2.3
Want to track INCR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 22 days
Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company
InterCure Ltd. INCR has shown resilience in its H1 2024 performance despite facing significant challenges, according to equity research by Pablo Zuanic of Zuanic & Associates.
Benzinga | 10 months ago
InterCure: A Cannabis Industry Leader Still Flying Under The Radar
InterCure is a leading pharmaceutical/medical cannabis company based in Israel and a global leader outside North America. Despite the damage the Hamas attack and the state of war in Israel caused, the company managed to sustain operations and present a positive 2023 ER. The company is entitled to full compensation from the Israeli government for the damage taken.
Seekingalpha | 1 year ago
2025 © Marketlog. All Rights Reserved.
